The groundbreaking approach of this peptide represents a major development in the management of type 2 diabetes. Unlike existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatidepeptide976176.arwebo.com/64586825/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment